This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Tim Wilsdon and Antun Sablek present their new study analyzing the expected impact of the GPL on the biotechnology innovation ecosystem. The webinar will discuss the consequences of this landmark legislation for the future of innovation in healthcare in Europe, EU patients and economies within a global race towards health security and competitiveness.
For more information on this event, click here.
Introduction and how the sampling industry works The landscape of market research sampling has had to evolve significantly in recent years. AI-driven bots are...
What would happen to the healthcare system without antibiotics? The responsible use of antibiotics requires minimizing their usage, which discourages...
